To further investigate the relations between the cell decrease and proliferation ability, we looked at the association of the CKAP2L versus the commonly used proliferation biomarkers in the TCGA dataset, including MKI67 [25] and MCM6 [25,26,27] expression, which have been used in other brain tumor studies. The gene discussed is CKAP2L; the disease is brain neoplasm.